Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recently, The Transplantation Society convened a workshop to address the question, "What do we need to have in place to make tolerance induction protocols a 'standard of care' for organ transplant recipients over the next decade?" In a productive 2-day meeting, there was wide-ranging discussion on a broad series of topics, resulting in five consensus recommendations as follows: (1) establish a registry of results for patients enrolled in tolerance trials; (2) establish standardized protocols for sample collection and storage; (3) establish standardized biomarkers and assays; (4) include children 12 years and older in protocols that have been validated in adults; and (5) establish a task force to engage third-party payers in discussions of how to fund tolerance trials. Future planned workshops will focus on progress in implementing these recommendations and identifying other steps that the community needs to take.

Original publication

DOI

10.1097/TP.0000000000000260

Type

Journal article

Journal

Transplantation

Publication Date

27/07/2014

Volume

98

Pages

117 - 121

Keywords

Adult, Age Factors, Biomarkers, Child, Clinical Protocols, Evidence-Based Medicine, Graft Rejection, Graft Survival, Humans, Immunosuppression, Organ Transplantation, Registries, Risk Factors, Time Factors, Transplantation Tolerance, Treatment Outcome